Vasocidin Ophthalmic Drops, Solution 10-0.25pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Vasocidin: Ophthalmic drops, solution (10-0.25%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

PREDNISOLONE; SULFACETAMIDE (pred NISS oh lone; sul fa SEE ta mide) is a combination of a steroid and a sulfa antibiotic. It helps to reduce swelling, redness, and itching of the eye. It also is used to treat eye infections.

In-Depth Information

Vasocidin 0.25%-10% Ophthalmic Solution

NDC: 587680887
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Uveitis, Corneal Abrasion, Ocular Inflammation, Bacterial Conjunctivitis

Vasocidin 0.25%-10% Ophthalmic Solution

Reported Side Effects for Vasocidin 0.25%-10% Ophthalmic Solution

High Eye Blood Pressure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Eye Irritation Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Itchy Eyes Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Vasocidin

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5